BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2321 related articles for article (PubMed ID: 15122913)

  • 21. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
    Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
    FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate specificity of native and mutated cytochrome P450 (CYP102A3) from Bacillus subtilis.
    Lentz O; Urlacher V; Schmid RD
    J Biotechnol; 2004 Feb; 108(1):41-9. PubMed ID: 14741768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system.
    Lentz O; Feenstra A; Habicher T; Hauer B; Schmid RD; Urlacher VB
    Chembiochem; 2006 Feb; 7(2):345-50. PubMed ID: 16381045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning, expression and characterisation of CYP102A7, a self-sufficient P450 monooxygenase from Bacillus licheniformis.
    Dietrich M; Eiben S; Asta C; Do TA; Pleiss J; Urlacher VB
    Appl Microbiol Biotechnol; 2008 Jul; 79(6):931-40. PubMed ID: 18483737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
    Udit AK; Arnold FH; Gray HB
    J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
    Cryle MJ; De Voss JJ
    Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochrome P450 BM3.
    Ost TW; Miles CS; Munro AW; Murdoch J; Reid GA; Chapman SK
    Biochemistry; 2001 Nov; 40(45):13421-9. PubMed ID: 11695888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
    Gonvindaraj S; Li H; Poulos TL
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty-acid-displaced transcriptional repressor, a conserved regulator of cytochrome P450 102 transcription in Bacillus species.
    Gustafsson MC; Palmer CN; Wolf CR; von Wachenfeldt C
    Arch Microbiol; 2001 Dec; 176(6):459-64. PubMed ID: 11734890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermodynamic and biophysical characterization of cytochrome P450 BioI from Bacillus subtilis.
    Lawson RJ; Leys D; Sutcliffe MJ; Kemp CA; Cheesman MR; Smith SJ; Clarkson J; Smith WE; Haq I; Perkins JB; Munro AW
    Biochemistry; 2004 Oct; 43(39):12410-26. PubMed ID: 15449931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP86A1 from Arabidopsis thaliana encodes a cytochrome P450-dependent fatty acid omega-hydroxylase.
    Benveniste I; Tijet N; Adas F; Philipps G; Salaün JP; Durst F
    Biochem Biophys Res Commun; 1998 Feb; 243(3):688-93. PubMed ID: 9500987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
    Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
    Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3.
    Govindaraj S; Poulos TL
    Biochemistry; 1995 Sep; 34(35):11221-6. PubMed ID: 7669780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
    Chen HC; Swenson RP
    Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
    Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
    Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
    Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 117.